In this presentation we, FIBD Business, a department of Global Project Funding AG in Switzerland, want to present to you and create awareness about Mosquito related diseases and how you can reduce the risk of mosquito bite with a new, natural and patented Mosquito Repellent. CHIKUNBLOCK - The Natural Mosquito Repellant, a thee in one product that combines Repellant, Sun Block and Skin Moisturizer CHIKUNBLOCK has been created in Puerto Rico / USA, that, at the time, is suffering an epidemic of the Chungunya Mosquito and that is rapidly spreading Chikungunya fever throughout the country. Check out this presentation for more details...

2. CHIKUNBLOCK PRESENTATION
In this presentation we want to present to you and create awareness
about Mosquito related diseases and how you can reduce the risk of
mosquito bite with a new, natural and patented Mosquito Repellent.
CHIKUNBLOCK - The Natural Mosquito Repellant, a thee in one
product that combines Repellant, Sun Block and Skin Moisturizer
CHIKUNBLOCK has been created in Puerto Rico / USA, that, at the
time, is suffering an epidemic of the Chungunya Mosquito and that is
rapidly spreading Chikungunya fever throughout the country.

3. CHIKUNBLOCK PRESENTATION
We also want to create awareness to the business opportunity related
with this unique CHIKUNBLOCK product. .
CHIKUNBLOCK is now being offered by Global Project Funding AG
(department FIBD Business) to international Importers, Distributors
and Whole Sellers for exclusive distribution. If you are in the Skin Care,
Insect Repellent Business are Travel Business this could be a very
interesting new product for you portfolio.
Many countries suffer from the bites from these little beasts, called
Mosquito. CHIKUNBLOCK an Interesting Business Opportunity!

4. Let’s stop the new virus!
Chikungunya is a virus
transmitted by a mosquito bite

5. MOSQUITO BORN ILLNESSES
INCLUDE:
• Malaria
• Dengue
• West Nile Virus
• Chikungunya
• Yellow Fever
• Japanese Encephalitis
• St Louis Encephalitis
• Western Equine Encephalitis
• Venezuelan Equine Encephalitis
• Eastern Equine Encephalitis
• La Crosse Virus

6. INSECTICIDE & INSECT REPELLANT
Our planet is not only covered in insecticides, pesticides and other
toxic chemicals, but these detrimental substances are in the air, soil,
our bodies and water supplies; 97% in America contain DEET!
Each year over 200,000 people die from pesticide poisoning. DEET
is the only pesticide allowed to be put directly on people's skin!!
It is hardly surprising that cancer rates are rising with all of this
chemical bombardment on our bodies and the environment around
us. Yes, bugs & mosquitos can be bad, especially when carrying
deadly diseases but there is no need for this chemical overkill when
there is a natural, safer alternative….

8. THE IDEAL PRODUCT WOULD HAVE:
o Natural Insect Repellent Properties
Yykkss,this
stuff is natural!
OMG! I got to
get away from
here!

9. o Sunblock Properties
Skin
SunBlock
THE IDEAL PRODUCT WOULD HAVE:

10. o Skin Moisturizing Properties
THE IDEAL PRODUCT WOULD HAVE:

11. The Solution:
CHIKUNBLOCK
o Natural Insect Repellent
o Sunblock / SPF30
o Moisturizing Lotion
ALL IN ONE!

12. First Product:
CHIKUNBLOCK

13. First Product:
CHIKUNBLOCK Label

14. CHIKUNBLOCK is made in
Salinas, Puerto Rico / USA

15. CHIKUNBLOCK Patent
Number…
o Mosquito Repellent Patent No.
o US 8,691,299 B2

17. UNIQUE SELLING POINT &
CONSUMER INTEREST
• 100% Natural Mosquito Repellent Formulation, Eco-friendly, no
harmful effects of chemicals.
• Excellent for caring adults & children
• 4 to 6 Hours Protection
• Prevents mosquito bites from infectious diseases such as; Dengue,
Malaria, West Nile Virus and nowadays the Chikungunya Virus.

18. UNIQUE SELLING POINT &
CONSUMER INTEREST
• No smells, no oils, no tradeoffs.
• Application is easy, no mess.
• An added benefit of a Sun Protector Factor (SPF30)
• And also an added benefit of a cream moisturizing lotion with a
delicate scent.

19. UNIQUE SELLING POINT &
CONSUMER INTEREST
No smells, no oils, no tradeoffs, Application is easy, no mess, An
added benefit of a Sun Protector Factor (SPF30), And also an
added benefit of a cream moisturizing lotion with a delicate scent.

20. UNIQUE COMPOSITION
Contains Natural substances like:
• Jojoba
• Aloe Vera
• Argan Oil
• Lemon extract
• Peppermint extract
• Vitamins C, B1, B2, B6, B12

21. EASYTO USE
To achive best results:
• Spread evenly and consistantly over all over all
exposed skin.
• Apply to hand for application and rub on
• The product schold not be applied to eyes & mouth
• Should be reapplied every 4 to 6 hours
• Reapplication also after swimming, perspiration,
vigorous activity or toweling
• Caution for people allergic to sunblock products

23. CHALLENGES
• Requires a considerate investment in marketing and
promotion for market introduction.
• New brand
• New product

24. The development of new products such as:
• CHIKUNBLOCK SPRAY
• CHIKUNBLOCK 100% Natural Juices
• CHIKUNBLOCK Water
• CHIKUNBLOCK Add On – An envelope like equal that could be added
to any drink.
• CHIKUNBLOCK - Mosquito Repellent Natural Pill.
• CHIKUNBLOCK Syrup
CHALLENGES

27. CHICUGUNYAVIRUS
• Chikungunya (pronunciation: chik-en-gun-ye) virus is transmitted to
people by mosquitoes.
• The most common symptoms of Chikungunya virus infection are fever
and joint pain. Other symptoms may include headache, muscle
pain, joint swelling, or rash.
• Outbreaks have occurred in countries in Africa, Asia, Europe, and
the Indian & Pacific Oceans. In late 2013, Chikungunya virus was
found for the first time in the Americas on islands in the Caribbean.

28. CHICUGUNYAVIRUS
• There is a risk that the virus will be imported to new areas by infected
travelers. There is no vaccine to prevent or medicine to treat
Chikungunya virus infection. Travelers can protect themselves by
preventing mosquito bites.
• When traveling to countries with Chikungunya virus, use insect
repellent, wear long sleeves & pants and stay in places with air
conditioning or that use window & door screens.

29. CHICUGUNYAVIRUS
Prevention
• No vaccine exists to prevent Chikungunya virus infection or disease.
• Prevent Chikungunya virus infection by avoiding mosquito bites
(see below).
• The mosquitoes that spread the Chikungunya virus bite mostly
during the daytime.

31. SAN JUAN, Puerto Rico (AP) -- Health officials in Puerto Rico on
Thursday declared an epidemic of the mosquito-borne virus known
as Chikungunya, which was introduced into the Caribbean region
late last year.
Health Secretary Ana Rius said that more than 200 cases had
been confirmed on the island as of June 25 and that the majority of
them were reported in the capital of San Juan and nearby areas.
The first case of Chikungunya in the U.S. territory was reported in
late May 2014.
PUERTO RICO DECLARES
CHIKUNGUNYA EPIDEMIC

32. Also on Thursday, officials in Jamaica reported the island's first
confirmed case. The chief medical officer, Dr. Kevin Harvey, said
the virus was found in a person who had recently traveled to a
country where there have been locally transmitted cases.
In Florida, health officials reported the first domestically acquired
Chikungunya infections in the United States. Officials said it
happened in two cases, both of which involved a person infected
with the virus after visiting the Caribbean being bitten again by an
uninfected mosquito in Florida, which then transmitted the
illness further.
PUERTO RICO DECLARES
CHIKUNGUNYA EPIDEMIC

33. Across the Caribbean, the Pan American Health Organization
recorded more than 354,000 suspected and confirmed cases as of
July 11. The Western Hemisphere's first locally transmitted case
was confirmed in December in the French Caribbean territory of St.
Martin.
Chikungunya was first identified in Africa in 1953. It causes a high
fever and severe pain in the joints, but is rarely fatal. There is no
vaccine, and it mainly is treated with pain medication.
PUERTO RICO DECLARES
CHIKUNGUNYA EPIDEMIC

35. DENGUE
• Dengue fever is an infectious disease caused by
the virus (DENV).
• It is transmitted by a mosquito within the genus
Aedes, principally the Aedes aegypti.
• The viral infection causes flu-like symptoms and
in occasions develops into a potentially life
threatening disease called hemorrhagic dengue.
• The mosquito is not affected by the virus but it is
used as a site for reproduction and transmission
of the virus.

36. • Dengue virus has become a serious public health hazard in Puerto
Rico, with many cases reported each year.
• In 2007, 11,000 cases were reported (and many more uncalled for)
with 8 of those ending in death!
• Because there is no vaccine, Public Health Officials in Puerto Rico
considered alternative methods like massive fumigation and public
education that includes how to recognize symptoms of Dengue Fever
and how to keep areas clean of standing water.
DENGUE IN PUERTO RICO

37. • Around 500 million people (more than 40% of the world
population) is at risk of contracting the Dengue Fever.
• Before 1970, nine countries in the world had suffered an
epidemic from the most severe type of virus, hemorrhagic
dengue.
• In 2010 1.6 million cases were reported in North and
South America only and 49,000 of those cases were
hemorrhagic Dengue
• In 2010 2.3 million cases were reported in total.
• Not only is the incidence of cases are increasing, but as
the virus expands to new areas and new outbreaks of the
virus are rapidly becoming life-threatening epidemics.
DENGUE AROUND THE WORLD

38. Treatment
• There is no specific treatment for
Dengue Fever.
• In the case of Hemorrhagic Dengue
Fever, medical assistance by
experienced doctors and nurses
familiar with evolution of the disease
may represent the difference between
life and death and may reduce
mortality rate from 20% to 1%.
• It is imperative to maintain the intake
of fluids. Dehydration is eminent.
Immunization
• There is no vaccine to protect us
against Dengue Fever.
• It has been very difficult to develop a
vaccine against the Dengue Fever, but
in recent years improvements have
been made.
• Various vaccines are in trial and
developmental phases.
DENGUE TREATMENT & IMMUNIZATION

40. • Malaria Is a mosquito-borne zoonotic arbovirus.
• This is found in temperate and tropical regions of the world.
• It was first identified in the West Nile sub region in the east African
region of Uganda in 1937.
• The main mode of WNV transmission is via various species of
mosquitoes, which are the prime vector, with birds being the most
commonly infected animal and serving as the prime reservoir host –
specially passerines, which are of largest birds.
WEST NILE VIRUS

41. • WNV also affects various mammal species, including humans, and
has been identified on reptilian species, including alligators and
crocodiles.
• Approximately 80% of the WNV infections in humans are
subclinical, which cause no symptoms.
• In the case where symptoms do occur the time from infection to the
appearance of symptoms is typically between 2 and 15
days. Symptoms may include fever, headaches, fatigue, muscle pain
or aches, malaise, nausea, anorexia, vomiting, myalgias and rash.
• Currently, no vaccine against WNV infection is available.
WEST NILE VIRUS

43. 39%
61%
REPELLENT SALES VS
POPULATION IN USA
Sales $200,000,000.00
Population 313,232,044

44. COMPETITION
• OFF!
• Real Kill
• Cutter
• Repel
• Raid
• Skinstastic

45. CONCLUSSION
No doubt we have render you with a breakthrough, this product
surpasses Off, Raid, and Cutter in benefits, effectiveness, and aroma.
With an effective Marketing Plan, our product will provide your
consumer’s with a healthy product that protects not only the skin,
and from sun rays, but also from a potentially deadly enemy that
nurses in our backyards!

46. Lets protect our Families & Children!
Don’t let the bugs and sun spoil your fun!
BEAT THEM UP WITH
CHIKUNBLOCK!

48. PRIVATE LABLE
If you like to sell Chikunblock under your own Band Name we are ready
to Private Label the product for you.
Conditions:
Min. order volume: 10’000pcs
Available sizes (existing packaging): 4oz / 118ml Bottles
Production lead time: 4-6weeks after delivery of design
Payment terms: in advance

50. CONTACT DETAILS
Global project Funding AG
Department FIBD Business
Samstagernstrasse 45
CH-8832 Wollerau
Switzerland
Tel: +41 (0)79 415 12 15
Web: www.fibdbusiness.com/chikunblock
Email : contact@gpf-switzerland.com